Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.

MLA

Bchir, Sarra, et al. “Matrix Metalloproteinase-9 (279R/Q) Polymorphism Is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.” Molecular Diagnosis & Therapy, vol. 19, no. 6, Dec. 2015, pp. 375–87. EBSCOhost, https://doi.org/10.1007/s40291-015-0163-2.

APA

Bchir, S., Nasr, H., Hakim, I., Anes, A., Yacoub, S., Garrouch, A., Benzarti, M., Bauvois, B., Tabka, Z., & Chahed, K. (2015). Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease. Molecular Diagnosis & Therapy, 19(6), 375–387. https://doi.org/10.1007/s40291-015-0163-2

Chicago

Bchir, Sarra, Hela Nasr, Imen Hakim, Amel Anes, Saloua Yacoub, Abdelhamid Garrouch, Mohamed Benzarti, Brigitte Bauvois, Zouhair Tabka, and Karim Chahed. 2015. “Matrix Metalloproteinase-9 (279R/Q) Polymorphism Is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.” Molecular Diagnosis & Therapy 19 (6): 375–87. doi:10.1007/s40291-015-0163-2.